Cadrenal Therapeutics CVKD
NASDAQ CVKD
$1.02 -0.02 (-1.92%)
At close: Oct 21, 2026 · 4:00 PM EDT

Cadrenal Therapeutics (CVKD) Capital Expenditures (2022 - 2025)

Updated

Cadrenal Therapeutics' Capital Expenditures was $5,104 in FY2025, down 21.9% from $6,537 in FY2024.

Analysis

Cadrenal Therapeutics (CVKD) Capital Expenditures (2022 - 2025) Analysis & Trends

From FY2022 onward, Cadrenal Therapeutics has reported Capital Expenditures for 4 years.

  • Capital Expenditures shows a three-year compound annual growth rate of 30.8% (FY2022 to FY2025).
  • Annual Capital Expenditures has moved between $2,279 (FY2022) and $6,537 (FY2024) over five years.
  • Per Business Quant data, Capital Expenditures in earlier years was $6,537 in FY2024 (+100.9%), $3,254 in FY2023 (+42.8%) and $2,279 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.32 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 322.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 1.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 140.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 533.00 Mn
10 Cadrenal Therapeutics 2.95 Mn -9.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 1,853.00
Mar 31, 2025 3,251.00
Sep 30, 2023 1.00
Dec 31, 2022 1.00
API Access

Cadrenal Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CVKD&period=max&api_key=YOUR_API_KEY